Characterization of NKR + T-cell subsets in human bone marrow: Implications for immunosurveillance of neoplasia

Clinical Immunology

Volumn 114, Issue 1, 2005, Pages 42-51

  Dean, J ^a   McCarthy, D ^a   Lawler, M ^b   Doherty, D G ^c   O'Farrelly, C ^a,d   Golden Mason, L ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bone marrow; Immunosurveillance; Neoplasia

Indexed keywords

CD8 ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D; T LYMPHOCYTE RECEPTOR;

ARTICLE; BIOLISTIC TRANSFORMATION; BLOOD SAMPLING; BONE MARROW BIOPSY; CONTROLLED STUDY; DATA ANALYSIS; DONOR; EXPOSURE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; NATURAL KILLER CELL; NEOPLASM; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

BIOLOGICAL MARKERS; BONE MARROW CELLS; FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOLOGIC SURVEILLANCE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS;

EID: 10444268776     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.08.017     Document Type: Article

References (47)

1. P. Clark, D.E. Normansell, D.J. Innes, and C.E. Hess Lymphocyte subsets in normal bone marrow Blood 67 1986 1600 1606
2. A.S. Fauci Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals J. Clin. Invest. 56 1975 98 110
3. G. Janossy, N. Tidman, W.S. Selby, J.A. Thomas, S. Granger, P.C. Kung, and G. Goldstein Subpopulations of human T lymphocytes occupy different microenvironments Int. J. Immunopharmacol. 3 1981 209 225
4. I.G. Schmidt-Wolf, S. Dejbakhsh-Jones, N. Ginzton, P. Greenberg, and S. Strober T-cell subsets and suppressor cells in human bone marrow Blood 80 1992 3242 3250
5. K. Theilgaard-Monch, K. Raaschou-Jensen, H. Palm, K. Schjodt, C. Heilmann, L. Vindelov, N. Jacobsen, and E. Dickmeiss Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts Bone Marrow Transplant. 28 2001 1073 1082
6. W. Zeng, J.P. Maciejewski, G. Chen, A.M. Risitano, M. Kirby, S. Kajigaya, and N.S. Young Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia Br. J. Haematol. 119 2002 803 809
7. S. Fujii, K. Shimizu, V. Klimek, M.D. Geller, S.D. Nimer, and M.V. Dhodapkar Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes Br. J. Haematol. 122 2003 617 622
8. J. Brittenden, S.D. Heys, J. Ross, and O. Eremin Natural killer cells Cancer 77 1996 1226 1243
9. E. Zorn, and T. Hercend A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation Eur. J. Immunol. 29 1999 592 601
10. M.H. Hsieh, and A.E. Patterson T-cell subsets mediate graft-versus-myeloid leukemia responses via different cytotoxic mechanisms Biol. Blood Marrow Transplant. 6 2000 231 240
11. S. Norris, C. Collins, D.G. Doherty, F. Smith, G. McEntee, O. Traynor, N. Nolan, J. Hegarty, and C. O'Farrelly Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes J. Hepatol. 28 1998 84 90
12. A.C. Hayday [gamma][delta] cells: a right time and a right place for a conserved third way of protection Annu. Rev. Immunol. 18 2000 975 1026
13. J.J. Campbell, K.E. Murphy, E.J. Kunkel, C.E. Brightling, D. Soler, Z. Shen, J. Boisvert, H.B. Greenberg, M.A. Vierra, S.B. Goodman, M.C. Genovese, A.J. Wardlaw, E.C. Butcher, and L. Wu CCR7 expression and memory T cell diversity in humans J. Immunol. 166 2001 877 884
14. C. Lundqvist, V. Baranov, S. Hammarstrom, L. Athlin, and M.L. Hammarstrom Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium Int. Immunol. 7 1995 1473 1487
15. J. O'Keeffe, D.G. Doherty, T. Kenna, K. Sheahan, D.P. O'Donoghue, J.M. Hyland, and C. O'Farrelly Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer Eur. J. Immunol. 2004 2110 2119
16. Y. Dang, J. Beckers, C.R. Wang, and K.D. Heyborne Natural killer 1.1(+) alpha beta T cells in the periimplantation uterus Immunology 101 2000 484 491
17. B.J. Nickoloff, B. Bonish, B.B. Huang, and S.A. Porcelli Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system J. Dermatol. Sci. 24 2000 212 225
18. K. Kurosu, N. Yumoto, W.N. Rom, Y. Takiguchi, J. Jaishree, K. Nakata, K. Tatsumi, A. Mikata, T. Kuriyama, and M.D. Weiden Oligoclonal T cell expansions in pulmonary lymphoproliferative disorders: demonstration of the frequent occurrence of oligoclonal T cells in human immunodeficiency virus-related lymphoid interstitial pneumonia Am. J. Respir. Crit. Care Med. 165 2002 254 259
19. H.R. MacDonald NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function J. Exp. Med. 182 1995 633 638
20. M. Brigl, and M.B. Brenner CD1: antigen presentation and T cell function Annu. Rev. Immunol. 22 2004 817 890
21. K. Takeda, S. Seki, K. Ogasawara, R. Anzai, W. Hashimoto, K. Sugiura, M. Takahashi, M. Satoh, and K. Kumagai Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis J. Immunol. 156 1996 3366 3373
22. T. Kawamura, K. Takeda, S.K. Mendiratta, H. Kawamura, L. Van Kaer, H. Yagita, T. Abo, and K. Okumura Critical role of NK1+ T cells in IL-12-induced immune responses in vivo J. Immunol. 160 1998 16 19
23. J. Cui, T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors Science 278 1997 1623 1626
24. S. Porcelli, D. Gerdes, A.M. Fertig, and S.P. Balk Human T cells expressing an invariant V alpha 24-J alpha Q TCR alpha are CD4- and heterogeneous with respect to TCR beta expression Hum. Immunol. 48 1996 63 67
25. O. Lantz, and A. Bendelac An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans J. Exp. Med. 180 1994 1097 1106
26. H. Arase, N. Arase, K. Nakagawa, R.A. Good, and K. Onoe NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion Eur. J. Immunol. 23 1993 307 310
27. T. Takahashi, M. Nieda, Y. Koezuka, A. Nicol, S.A. Porcelli, Y. Ishikawa, K. Tadokoro, H. Hirai, and T. Juji Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells J. Immunol. 164 2000 4458 4464
28. M. Kronenberg, and L. Gapin The unconventional lifestyle of NKT cells Nat. Rev. Immunol. 2 2002 557 568
29. M. Exley, J. Garcia, S.P. Balk, and S. Porcelli Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells J. Exp. Med. 186 1997 109 120
30. M.A. Exley, S.M. Tahir, O. Cheng, A. Shaulov, R. Joyce, D. Avigan, R. Sackstein, and S.P. Balk A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses J. Immunol. 167 2001 5531 5534
31. M. Sykes Unusual T cell populations in adult murine bone marrow. Prevalence of CD3+ CD4-CD8- and alpha beta TCR+NK1.1+ cells J. Immunol. 145 1990 3209 3215
32. G. Eberl, R. Lees, S.T. Smiley, M. Taniguchi, M.J. Grusby, and H.R. MacDonald Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells J. Immunol. 162 1999 6410 6419
33. D.G. Doherty, S. Norris, L. Madrigal-Estebas, G. McEntee, O. Traynor, J.E. Hegarty, and C. O'Farrelly The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns J. Immunol. 163 1999 2314 2321
34. S. Norris, D.G. Doherty, C. Collins, G. McEntee, O. Traynor, J.E. Hegarty, and C. O'Farrelly Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells Hum. Immunol. 60 1999 20 31
35. L.H. Martin, F. Calabi, and C. Milstein Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens Proc. Natl. Acad. Sci. U. S. A. 83 1986 9154 9158
36. A. Bradbury, K.T. Belt, T.M. Neri, C. Milstein, and F. Calabi Mouse CD1 is distinct from and co-exists with TL in the same thymus EMBO J. 7 1988 3081 3086
37. F. Calabi, J.M. Jarvis, L. Martin, and C. Milstein Two classes of CD1 genes Eur. J. Immunol. 19 1989 285 292
38. S.D. Gadola, N. Dulphy, M. Salio, and V. Cerundolo Valpha24-JalphaQ- independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes J. Immunol. 168 2002 5514 5520
39. L.L. Lanier, C. Chang, and J.H. Phillips Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes J. Immunol. 153 1994 2417 2428
40. Y. Shimizu, S. Iwatsuki, R.B. Herberman, and T.L. Whiteside Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors Int. J. Cancer 46 5 1990 Nov. 15 878 883
41. B. Ostenstad, T. Lea, E. Schlichting, and M. Harboe Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area Gut 35 3 1994 Mar. 382 387
42. Y. Takii, S. Hashimoto, T. Iiai, H. Watanabe, K. Hatakeyama, and T. Abo Increase in the proportion of granulated CD56+T cells in patients with malignancy Clin. Exp. Immunol. 97 3 1994 Sep. 522 527
43. T. Okada, T. Iiai, Y. Kawachi, T. Moroda, Y. Takii, K. Hatakeyama, and T. Abo Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer Clin. Exp. Immunol. 102 1 1995 Oct. 159 166
44. T. Yoshimoto, and W.E. Paul CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3 J. Exp. Med. 179 1994 1285 1295
45. J. Pinilla-Ibarz, K. Cathcart, T. Korontsvit, S. Soignet, M. Bocchia, J. Caggiano, L. Lai, J. Jimenez, J. Kolitz, and D.A. Scheinberg Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses Blood 95 2000 1781 1787
46. B.D. Harrison, J.A. Adams, M. Briggs, M.L. Brereton, and J.A. Yin Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia Blood 97 2001 2764 2771
47. + T cells J. Immunol. 164 2000 2009 2015